Accumulating evidence shows that cancer cells exploit HIF-1-mediated pathways to promote tumor progression by activating the hallmarks of cancer, such as cell proliferation, glucose metabolism, metastasis, angiogenesis, and drug resistance [10]. This evidence concerns the gene HIF1A and cancer.